1. Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin 
Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John W.D. McDonald, Albert Cohen, Alain Bitton, Jeffrey Baker, Réjean Dubé, Steven B. Landau, Margaret K. Vandervoort, Asit Parikh 
Clinical Gastroenterology and Hepatology 
Volume 6, Issue 12, Pages (December 2008)
DOI: /j.cgh
Copyright © 2008 AGA Institute Terms and Conditions

2. Figure 1 Patient disposition.
Clinical Gastroenterology and Hepatology 2008 6, DOI: ( /j.cgh )
Copyright © 2008 AGA Institute Terms and Conditions

3. Figure 2
Proportions of patients achieving (A) clinical response (≥70-point decrement in CDAI from baseline) and (B) clinical remission (CDAI ≤150) over the course of the study. *P value less than .05 versus placebo.
Clinical Gastroenterology and Hepatology 2008 6, DOI: ( /j.cgh )
Copyright © 2008 AGA Institute Terms and Conditions